Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.
Develops the Evoke closed-loop spinal cord stimulation system, the first SCS device that senses the spinal cord's ECAP response and adjusts therapy on every pulse.
Join to open the full comparison.
The Briefing, free for life.